| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $35.9M | +1.0% |
| R&D Expense | $104.2M | -5.8% |
| SG&A Expense | $36.2M | -14.1% |
| Operating Income | -$115.2M | +3.7% |
| Pre-tax Income | -$104.9M | +0.3% |
| Income Tax | $121K | -7.6% |
| Net Income | -$105.0M | +0.3% |
| EPS (Basic) | -$1.27 | +16.4% |
| EPS (Diluted) | -$1.27 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $74.6M | +34.4% |
| Accounts Receivable | $2.4M | -22.6% |
| Current Assets | $258.1M | +0.1% |
| Total Assets | $359.1M | +2.7% |
| Current Liabilities | $33.0M | -26.9% |
| Total Liabilities | $102.5M | -23.3% |
| Stockholders' Equity | $256.6M | +18.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$98.7M | -51.5% |
| Capital Expenditures | $607K | +237.2% |
| Investing Cash Flow | -$8.6M | +83.2% |
| Financing Cash Flow | $126.4M | +178.8% |
| Free Cash Flow | -$99.3M | -52.0% |
| +16.4% |